Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director directly owned 75,518 shares in the company, valued at $868,457. The trade was a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Viemed Healthcare Stock Down 0.5%
VMD opened at $11.63 on Friday. Viemed Healthcare, Inc. has a twelve month low of $5.93 and a twelve month high of $11.88. The company’s 50-day moving average price is $9.91 and its two-hundred day moving average price is $8.84. The stock has a market cap of $445.89 million, a price-to-earnings ratio of 31.43 and a beta of 1.12. The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03). The firm had revenue of $75.41 million during the quarter, compared to analysts’ expectations of $74.40 million. Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%. As a group, equities analysts expect that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.
Hedge Funds Weigh In On Viemed Healthcare
About Viemed Healthcare
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.
See Also
- Five stocks we like better than Viemed Healthcare
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
